Sensitivity to macrophages decreases with tumor progression in the AKR lymphoma.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/0-306-46831-X_23PMID 10897427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood in a Haab Stria

  2018cited by this paper
• The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.

  1999cited by this paper
• Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma.

  1999cited by this paper
• Differing expression of MMPs‐1 and ‐9 and urokinase receptor between diffuse‐ and intestinal‐type gastric carcinoma

  1999cited by this paper
• Fibrin Deposition in Squamous Cell Carcinomas of the Larynx and Hypopharynx

  1998cited by this paper
• Therapy of cancer metastasis by activation of the inducible nitric oxide synthase

  1998cited by this paper
• Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.

  1998cited by this paper
• Synergistic Antitumor Interaction of Human Monocyte Chemotactant Protein-1 Gene Transfer and Modulator for Tumor-Infiltrating Macrophages

  1998cited by this paper
• Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.

  1998cited by this paper
• [Host reactions affect cancer progression].

  1998cited by this paper
• Biological behavior and cell properties of new AKR lymphoma malignancy variants.

  1998cited by this paper
• Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators.

  1998cited by this paper
• Metastasis-associated cell functions in AKR lymphoma malignancy variants.

  1995cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• Differential metastatic capacity of three AKR lymphoma variants.

  1992cited by this paper
• Cellular functions related to metastasis differing between low- and high-malignancy variants of AKR lymphoma.

  1992cited by this paper
• Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

  1988cited by this paper
• Inflammatory infiltrates of experimental mammary cancers.

  1986cited by this paper
• A model for cancer treatment in advanced compared to early cancer.

  1986cited by this paper
• Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis.

  1985cited by this paper
• Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.

  1985cited by this paper
• Different biological behavior of AKR lymphoma cells from primary and metastatic tumors

  1985cited by this paper
• Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs.

  1984cited by this paper
• Macrophage oxidative burst and related cytotoxicity. I. Differential activation by tumor‐promoting and non‐tumor‐promoting phorbol esters

  1984cited by this paper
• Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity

  1983cited by this paper
• Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes

  1981cited by this paper
• Role of Natural Killer Cells in the Destruction of Circulating Tumor Emboli

  1980cited by this paper
• Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice.

  1980cited by this paper
• Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.

  1980cited by this paper
• Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.

  1979cited by this paper
• The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer

  1978cited by this paper
• Tissue T and B cell infiltration of primary and metastatic cancer.

  1976cited by this paper
• The stromal reaction of tumors: an expression of immune surveillance.

  1976cited by this paper
• Heterocytolysis by Macrophages Activated by Bacillus Calmette-Gu�rin: Lysosome Exocytosis into Tumor Cells

  1974cited by this paper
• Tumor‐associated immunoglobulins. enhancement of syngeneic tumors by igg2‐containing tumor eluates

  1972cited by this paper
• Tumor-associated immunoglobulins.

  1971cited by this paper
• CUTANEOUS BASOPHIL HYPERSENSITIVITY

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Designing ageing conditions in tumour microenvironment-a new possible modality for cancer treatment.

  2009cites this paper